Product Overview

Dydrogesterone 10 mg is a synthetic oral progestogen manufactured by Abbott India Pvt. Ltd. and marketed as a generic medication for the management of endometriosis, female infertility, and dysmenorrhea (painful menstruation). Each strip contains ten tablets, and the product is available in pack sizes of 30, 60, or 90 tablets, providing flexible dosing options for patients and clinicians.

What is Dydrogesterone 10 mg?

Dydrogesterone belongs to the class of non‑steroidal progestins that mimic the action of natural progesterone on the endometrium without the androgenic or estrogenic side effects associated with many other progestogens. The active ingredient is chemically designated as 6α‑hydroxy‑progesterone acetate, and the 10 mg tablet strength is the most commonly prescribed dose for the indicated conditions. This medication is listed in standard formularies and is recognized by the Indian Pharmacopoeia as a therapeutic equivalent to branded progestogenic agents used in reproductive health.

Uses and Benefits

The primary therapeutic uses of Dydrogesterone 10 mg include:

• Long‑term suppression of endometrial hyperplasia in women with endometriosis, reducing inflammatory lesions and associated pelvic pain
• Adjunctive treatment of luteal phase deficiency, supporting implantation in assisted reproductive technology (ART) cycles
• Reduction of menstrual pain and heavy bleeding in patients with abnormal uterine bleeding related to hormonal imbalance

Clinical studies have demonstrated that continuous use of Dydrogesterone improves quality of life scores and lowers the need for rescue analgesic medication, making it a valuable option for women seeking non‑invasive, hormone‑based therapy

How It Works

Dydrogesterone exerts its pharmacological effect by binding to the intracellular progesterone receptor (PR) and modulating gene transcription in the endometrial lining. Unlike many progestins, it does not significantly affect lipid metabolism or cardiovascular parameters, which contributes to its favorable safety profile. The drug’s selective receptor activity helps maintain a stable endometrial environment, preventing the proliferation of ectopic endometrial tissue that characterizes endometriosis, while also supporting the secretory phase necessary for embryo implantation

Dosage Guidelines

Typical adult dosing for Dydrogesterone 10 mg is one tablet taken two to three times daily, depending on the clinical indication and physician guidance. For endometriosis, a common regimen is 10 mg three times per day for the first 12–16 weeks, followed by a maintenance dose of 10 mg twice daily if symptoms remain controlled. In fertility treatment protocols, the medication is often started on day 1 of the luteal phase and continued until a pregnancy test is performed. Patients should always follow the dosing schedule prescribed by their healthcare provider and should not adjust the dose without medical supervision. The tablets should be swallowed whole with water and can be taken with or without food

Side Effects

Like all medications, Dydrogesterone may cause adverse effects, although most are mild and transient. Commonly reported side effects include:

• Headache
• Nausea or mild gastrointestinal discomfort
• Breast tenderness
• Fluid retention

Rare but serious adverse reactions require immediate medical attention, such as severe allergic reactions (rash, swelling, difficulty breathing), signs of thromboembolic events (leg pain, sudden shortness of breath), or marked mood changes. If any of these symptoms occur, patients should contact their physician promptly

Warnings and Precautions

Before initiating therapy with Dydrogesterone 10 mg, consider the following precautions:

• Contraindication in patients with known hypersensitivity to the drug or any of its excipients
• Use with caution in individuals with a history of thromboembolic disorders, liver disease, or unexplained vaginal bleeding
• Pregnant women should only use Dydrogesterone under explicit medical direction, as the safety profile during pregnancy is established but requires professional oversight
• Patients should inform their clinician of all concomitant medications, especially corticosteroids, anticoagulants, or other hormonal therapies, to avoid potential drug interactions

Regular monitoring through clinical examination and, when indicated, imaging studies helps ensure that treatment remains effective and safe over the course of therapy

Frequently Asked Questions

1. Can Dydrogesterone be taken with other hormonal medications? It is generally recommended to avoid combining Dydrogesterone with other progestins or estrogenic agents unless specifically directed by a physician, as combined hormonal therapy may increase the risk of side effects
2. How long does it take to notice improvement in pain symptoms? Most patients report a reduction in dysmenorrhea within the first menstrual cycle after starting treatment, with maximal benefit typically observed after 2–3 months of consistent use
3. Is Dydrogesterone safe for long‑term use? Clinical guidelines support continuous use for up to six months, after which a medical review should determine whether continuation is appropriate based on symptom control and tolerability
4. Where can I verify the drug’s regulatory status? Detailed prescribing information and safety data are available on authoritative sites such as the MedlinePlus and the NIH database
5. What should I do if I miss a dose? If a single dose is missed, the patient should take it as soon as remembered unless it is near the time of the next scheduled dose; in that case, the missed dose should be skipped and the regular schedule resumed. Double dosing is not recommended

For additional information on endometriosis management and fertility treatment protocols, reputable resources such as the Drugs.com monograph and the NIH provide evidence‑based guidance

Related Products

• Faceclin Gel (Clindamycin/Nicotinamide)
• Resteclin 500 mg (Tetracycline)
• Erythrocin 250 mg (Erythromycin)
• Flagyl 200mg (Metronidazole)
• Flagyl 400mg (Metronidazole)
• Flagyl (Metronidazole)
• Tetracycline 500 mg (Generic)
• Tetracycline 250 mg (Generic)
• Resteclin (Tetracycline)
• Resteclin 250 mg (Tetracycline)
• Erythrocin (Erythromycin)
• Bactrim DS (Sulfamethoxazole/Trimethoprim)